Cardio Diagnostics Holdings, Inc. CDIO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

48/100

2/7 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Cardio Diagnostics Holdings, Inc. (CDIO) generated $-1.36M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $17.02K, free cash flow was $-1.38M.

Free cash flow margin was -38786.8% of revenue. Cash conversion ratio was 0.93x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (0/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was 0.93x suggests some earnings are non-cash items

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

48/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

→ Valuation

✓

FUTURE

100/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

0/100

Proven by this page

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Cardio Diagnostics Holdings, Inc. Cash Flow History

Metric	TTM	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025
Operating Cash Flow	$-5.73M	$-1.36M	$-1.39M	$-1.57M	$-1.4M
Capital Expenditure	$-204.34K	$-17.02K	$-162.83K	$-18.7K	$-5.79K
Free Cash Flow	$-5.93M	$-1.38M	$-1.56M	$-1.59M	$-1.41M